CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
Clinical trial NCT05356403 · TERMINATED
Trial details
- NCT number
- NCT05356403
- Sponsor
- Cara Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2024-02-26
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.